Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3193-3198

  Utada, Yoshihito ^a,b,c   Emi, Mitsuru ^a   Yoshimoto, Masataka ^b   Kasumi, Fujio ^b   Akiyama, Futoshi ^b   Sakamoto, Goi ^b   Haga, Shunsuke ^c   Kajiwara, Tetsuro ^c   Nakamura, Yusuke ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CANCER INSTITUTE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CHROMOSOME 1P; CONTROLLED STUDY; DISEASE MARKER; GENE MUTATION; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 0033905182     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Callahan, R., and Campbell, G. Mutations in human breast cancer: an overview. J. Natl. Cancer Inst., 81: 1780-1786, 1989.
2. Knudson, A. G. Anti-oncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
3. Utada, Y., Kasumi, F., Yoshimoto, M., Tada, T., Saito, M., Takahashi, K., Akiyama, F., Sakamoto, G., and Nishi, M. The location of positive nodes partly influences the prognostic value of the number of positive nodes in breast cancer patients. Jpn. J. Clin. Oncol., 29: 63-67, 1999.
4. Harris, J. R., and Henderson, I. C. Staging and prognostic factors. In: J. R. Harris (ed.), Breast Diseases, pp. 327-346. Philadelphia: Lippincott, Williams, & Wilkins Publishers, 1987.
5. Fisher, B., Redmond, C., Fisher, R., and Caplan, R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients. J. Clin. Oncol., 6: 1076-1087, 1988.
6. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
7. Sato, T., Akiyama, F., Sakamoto, G., Kasumi, F., and Nakamura, Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51: 5794-5799, 1991.
8. Takita, K., Sato, T., Miyagi, M., Watanabe, M., Akiyama, F., Sakamoto, G., Kasumi, F., Abe, R., and Nakamura, Y. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res., 52: 3914-3917, 1992.
9. Saito, H., Inazawa, J., Saito, S., Kasumi, F., Koi, S., Sagae, S., Kudo, R., Saito, J., Noda, K., and Nakamura, Y. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res., 53: 3382-3385, 1993.
10. Harada, Y., Katagiri, T., Ito, I., Akiyama, F., Sakamoto, G., Kasumi, F., Nakamura, Y., and Emi, M. Genetic studies of 457 breast cancers: clinicopathologic parameters compared with genetic alterations. Cancer (Phila.), 74: 2281-2286, 1994.
11. Ito, I., Yoshimoto, M., Iwase, T., Watanabe, S., Katagiri, T., Harada, Y., Kasumi, F., Yasuda, S., Mitomi, T., Emi, M., and Nakamura, Y. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br. J. Cancer, 71: 438-441, 1995.
12. Tsukamoto, K., Ito, N., Yoshimoto, M., Iwase, T., Tada, T., Kasumi, F., Nakamura, Y., and Emi, M. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas. Cancer (Phila.), 78: 1929-1934, 1996.
13. Iida, A., Isobe, R., Yoshimoto, M., Kasumi, F., Nakamura, Y., and Emi, M. Localization of a breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16p22. Br. J. Cancer, 75: 264-267, 1997.
14. Matsumoto, S., Kasumi, F., Sakamoto, G., Onda, M., Nakamura, Y., and Emi, M. Detailed deletion mapping of chromosome arm 3p in breast cancer: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Genes Chromosomes Cancer, 20: 1-7, 1997.
15. Yokota, T., Matsumoto, S., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn. J. Cancer Res., 88: 959-964, 1997.
16. Iida, A., Kurose, K., Isobe, R., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer, 21: 108-112, 1998.
17. Nakata, T., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Identification of a new commonly deleted region within a 2-cM interval of 11p11 in breast cancers. Eur. J. Cancer, 34: 417-421, 1998.
18. Tsukamoto, K., Ito, N., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer (Phila.), 82: 317-322, 1998.
19. Japanese Breast Cancer Society. The general rules for clinical and pathological recording of breast cancer. Jpn. J. Surg., 19: 612-632, 1989.
20. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
21. McGuire, W., and Clark, G. Prognostic factors and treatment decision in axillary node-negative breast cancers. N. Engl. J. Med., 326: 1756-1761, 1992.
22. Michael, F. P., Leslie, B., Patricia, A. T., Lorraine, F. M., Zhou, J. Y., and Yanling, M. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. Clin. Oncol., 15: 2894-2904, 1997.
23. Elledge, R. M., Fuqua, S. A. W., Clark, G. M., Allred, D. C., and McGuire, W. L. Prognostic significance of p53 gene mutations in node-negative breast cancer. Breast Cancer Res. Treat., 26: 225-235, 1993.
24. Barry, I., Fabienne, G., Brenda, P., Richi, S., Kieran, M., and Ram, S. Analysis of p53 gene mutation by polymerase chain reaction: single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin. Cancer Res., 4: 1597-1602, 1998.
25. Kute, T. E., Hansen, J. G., Shao, S. M., Long, R., Russell, G., and Brunner, N. Low cathepsis D and low plasminogen activator type 1 inhibitor in tumor cytosis defines a group of node negative breast cancer patients with low risk of recurrence. Breast Cancer Res. Treat., 47: 9-16, 1998.
26. Neilsen, N. H., Arnerlov, C., Emdin, S. O., and Landberg, G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer., 74: 874-880, 1996.
27. Leister, I., Weith, A., Bruderlein, S., Cziepluch, C., Kangwanpong, D., and Schlag, P. Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res., 50: 7232-7235, 1990.
28. Praml, C., Finke, L. H., Herfarth, C., Schlag, P., Schwab, M., and Amler, L. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene, 11: 1357-1362, 1995.
29. Yer, S. H., Chen, P. J., Chen, H. L., Lai, M. Y., Wang, C. C., and Chen, D. S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res., 54: 4188-4192, 1994.
30. Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., and Kaanematsu, T. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer, 13: 163-167, 1995.
31. Wada, M., Yokota, J., Mizoguchi, H., Sugimura, T., and Terada, M. Infrequent loss of chromosomal heterozygosity in human stomach cancer. Cancer Res., 48: 2988-2992, 1988.
32. Ezaki, T., Yanagisawa, A., Ohta, K., Aiso, S., Watanabe, M., and Hibi, T. Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br. J. Cancer, 73: 424-428, 1996.
33. Takayama, H., Suzuki, T., Mugishima, H., Fujisawa, T., Ookuni, M., and Schwab, M. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene, 7: 1185-1189, 1992.
34. Maris, J. M., White, P. S., Beltinger, C. P., Sulman, E. P., Castleberry, R. P., and Shuster, J. J. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res., 55: 4664-4669, 1995.
35. White, P. S., Maris, J. M., Beltinger, C. P., Sulman, E. P., Marshall, H. N., and Fujimori, M. A region of consistent deletion in neuroblastoma maps within human chromosome 136.2-36.3. Proc. Natl. Acad. Sci. USA, 92: 5520-5524, 1995.
36. Bello, M. J., Leone, P. E., Vaquero, J., Campos, J. M., Kusak, M. E., and Sarasa, J. L. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int. J. Cancer, 64: 207-210, 1995.
37. Mai, M., Huang, H., Reed, C., Qian, C., Smith, J. S., and Alderete, B. Genomic organization and mutation analysis of p73 in oligodendregliomas with chromosome 1p-arm deletions. Genomics, 57: 359-363, 1998.
38. Ishino, S., Hashimoto, N., Fushiki, S., Date, K., Mori, T., and Fujimoto, M. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer (Phila.), 83: 360-366, 1998.
39. Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., and Houseman, D. E. Loss of alleles from the distal shorted arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA, 86: 4614-4618, 1989.
40. Shin, E., Fujita, S., Takami, K., Kurahashi, H., Kurita, Y., and Kobayashi, T. Deletion mapping of chromosome 1p and 22q in pheochromocytoma. Jpn. J. Cancer Res., 84: 402-408, 1993